Browsing by Author "Belete Anteneh"
Now showing 1 - 5 of 5
Results Per Page
Sort Options
Item Challenges and Prospects of the Regional Bioequivalence Center Initiative in Ethiopia: a Qualitative Study.(Addis Abeba University, 2020-10) Melesse Yajeb; Hailu Asrat ; Belete AntenehBackground: Evaluation of the interchangeability of multi-source generic drug products or bioequivalencestudy has become a crucial activity since the share of generic medicines in healthcare has enormously grown over the past few decades. Among four East African Countries,namely, Ethiopia, Kenya, Uganda and Tanzania, there has been an initiative to establishan accessible and affordable BE center for the regional pharmaceutical manufacturers. Thisstudy aims at assessing the challenges and prospects of the bioequivalence center initiative inEthiopia. Methods: In-depth interview was conducted with individuals who were Ethiopian affiliates of the Regional Bioequivalence initiative; local pharmaceutica manufacturers, Ethiopian Food andDrug Administration, Regional Bioequivalence Center and other key stakeholders who are involvedin thecenter capacity building. Data were collected using digital voice recorders, andtranscribed. These data were analyzed using an inductive thematic analysis using Nvivo softwareand the findings were presented in narratives using the respondent‟s own words as illustrations. Results: Based on the findings, four major themes, one as an opportunity and threeaschallenges,wereidentified.ThemerepresenceoftheRegionalBioequivalenceCenterby itself was considered as an opportunity by most of theparticipants .Inaddition,anumber of favorable condition sincluding awareness and demandforproductqualityanddiversity,thepresenceofattractiveincentivepackages for local pharmaceutical manufacturers and the proliferation of the genericmedicines market in the region were mentioned as opportunities. On the other hand, lackof resources and stakeholders‟ commitment as well as lack of regulatory enforcement were identifiedaschallenges. Conclusions:The Bioequivalence center initiative has not functioned well as initially planned.The findings of this study suggest the need for government and key stakeholders to actively engagein the program to make the initiative viable. The significance of supporting this initiativecould positively contribute to the creation of a competitive local manufacturing sector that willengage in the production of therapeutically interchangeable generic products and ultimatelysafeguard the health of the society at large.Item The Effect of Human Resource Development (HRD) Practices on Perceived Employee Productivity at Dashen Bank Share Company(Addis Ababa University, 2018-05-19) Belete Anteneh; worku BantieThe purpose of this study is to investigate the effect of HRD on perceived employee productivity at Dashen Bank Share Company. The study focuses on the three HRD investment factors: training, career development, and financial support for education and their effect on employees’ productivity. The tree research questions and three hypotheses were formulated in line with the objectives of the study. A self-administered structured questionnaire was designed and distributed to 262 respondents. The researcher collected 251 responses and analyzed using descriptive statistics, correlation, and multiple regressions. The research assumptions are checked against the data gathered. Although training contributes for improved productivity of employees, most of the respondents agree on that most trainings do not allow them perform or apply what is learned back on the job. This is because of the training delivery method ignored the practical aspect. Another finding is that the management is not keen in counseling and providing direction to employees about their future career development. Based on the finding of the study the researcher forwarded his recommendations.Item Efficacy and Safety of Vaccine Trials Conducted in Africa: a Systematic Review and Meta-analysis.(Addis Ababa University, 2021) Tesfai Sara; Hailu Asrat; Belete AntenehBackground: vaccine preventable diseases have been of global concern. Vaccines are the best way for prevention. Studies are showing that there is disparity in efficacy of vaccines, in industrialized and in low-middle income countries. Additionally, vaccine related diseases aresaid to be occurring in recent decades. Africa produces less than one percent of vaccines anddepends on imports. It is important to check how many of these imported vaccines have been subjected to clinical trials, to assess efficacy and safety before they are made available to mass consumption. This study is aimed to evaluate the vaccine trials conducted up to the end of 2020 with no start up period limit to inventory the type of trials undertaken in comparison with thevaccines that are in routine use in African countries and to assess vaccine effectiveness in African settings. Methodology: A systematic review and meta-analysis was carried out to assess the vaccine trials conducted in the 54 African countries. Eighteen WHO approved registries, 2 immunization schedule sites and databases were searched. Data were exported to MS excel and RevMan version 5.4 for analysis. Result: The largest vaccine trial for disease prevention purpose was seen for malaria with 119 (21.2%) whereas the lowest was for tetanus with 1 (0.2%) trial. Out of these vaccines, BCG and OPV are given in all African countries, whereas vaccines for; Hepatitis A Influenza (for both pediatric and adult), MenAC, bOPV, deworming, cholera, DTaP, TdIPV and dtaPHibIP aregiven only in one country each. From the 26 single disease specific vaccine 17 and from 13 combination vaccines 4 multi-disease vaccines was found to have gone through clinical trial which ranges from the lower 1 ( Tetanus) vaccine trial per disease of interest to the highest of 119 (Malaria) vaccine trials in the single disease specific trials. BCG and OPV given in allAfrican countries (100%) attributed to only 55 (15.5 %) and 2 (0.5%) of the trials, respectively, whereas Malaria vaccine which is given only in 3 (5.5%) of African countries attributed to 119 (33.6%) of the trials. In the malaria vaccine trial review, highest efficacy [30%, 95% CI (0.59, 0.84)] was seen against severe malaria in both children and infants. Whereas, the lowest efficacy[20%, 95% CI (0.75, 0.86)] was found to be in 1st episode of malaria in infants. The highest efficacy [67%, 95% CI (0.16, 0.66)] was seen in HIV positive adults and the lowest efficacy [21%, 95% CI (0.44, 1.42)] was seen in HIV positive infants. The highest efficacy [52%, 95% CI (0.37, 0.61)] of the PCV vaccine was seen against 1st episode of IPD, and the lowest efficacy[13%, 95% CI (0.80, 0.96)] was seen against severe Pneumonia in HIV negative individuals. Conclusion: The overall efficacy of the three types of vaccines that are included in this review was found to be low, and no significant SAEs were found across the vaccines. We found no vaccines terminated for futility. Safety data of these studies were mainly acquired from phase 3 trials not phase 4, we couldn’t assess the safety issues identified from outside of a controlledenvironment i.e., for a long term effect and the issues seen in general populations.Item Evaluation of Taro Boloso-I Native (Colocasia esculenta Cultivar) Starch as Disintegrant and Its Pre-Gelatinized form as Direct Compression Diluent in Paracetamol Tablets(Addis Ababa University, 2016-01) Balcha Tamrat; Belete Anteneh ; Mary JosephTaro Boloso-I is a new variety of Colocasia esculenta (L. Schott) officially released from ArekaAgricultural Research Center, Areka, Ethiopia. Its cultivation out yields 67% more than a previouslyreported variety (Godare) in Ethiopia. It contains 85.65 ± 0.07% of carbohydrate on dry basis andhigher gross energy than the existing cultivars of taro reflecting its difference from the preexistingvarieties of taro. The aim of this study was to isolate, characterize the starch from this plant andevaluate its potential applications. It was also to evaluate the tablet disintegrant properties and direct compressibility of the pre-gelatinized form using paracetamol as a model drug. Starch was extracted from the C. esculenta by using saline solution (0.1N) and sodium hydroxide (0.03 N). Various13experimental methods were applied for characterization of the starch. Central composite design wasused for optimization of the levels and hence the responses. Yield of starch from Taro Boloso-I on dryweight basis was 83.5 ± 1.6%. The native Taro Boloso-I starch (NTB1S) was characterized by loweramylose to amylopectin ratio (20.7 ± 1.8% to 77.3 ± 2.1%, w/w) higher onset, peak and endsettemperatures of gelatinization than potato starch. Its granules were found to exhibit polyhedral/angularshape and A-type polymorphism comprising powder of poor flow. In all of these properties, TaroBoloso-I starch not only significantly differs from the previously reported taro varieties in Ethiopia butalso shares more of cereal starches (rice starch) than the tuber starches. Paracetamol tablet (350mg)prepared by wet granulation using NTB1S (9.80%) as disintegrant and compression force of 15kN hadhardness of 117.1 ± 4.93N, friability of 0.159 ± 0.02% and disintegration time of 1.31 ± 0.02 min. Thehardness, friability and balance between binding and disintegration were better than potato starch, 58.1± 2.57 N, 1.01 ± 0.06% and 46.4 ± 4, respectively. Moreover, the tablets fulfill the disintegrant timerequirements for fast dissolving tablets. The modified (optimized) Taro Boloso-I starch (PGTB1S) has comparable flow property but higher compressibility and compactibility. If used as a disintegrant inparacetamol tablets, NTB1S can result not only in better hardness and friability than the correspondingtablets with potato starch but also a kind of fast dissolving tablet. Also it was revealed that PGTB1Scan be used as efficient direct compression diluent with magnesium stearate tolerance of 0.5%. Its dilution potential was also better than Starch 1500®. Key words: Starch, tablet, compression, gelatinization, disintegrant, Taro Boloso-I, Kawakita, HeckelItem Relationship among Occupational Stressors, Job Dissatisfaction, Well-being, Organizational Commitment and Turnover Intention: The Case of Employees of the College of Health Sciences, Addis Ababa University Relationship among Occupational Stressors, Job Dissatisfaction(A.A.U, 2021-07) Belete Anteneh; Mekonen TsegabrhanThe higher education sector has been traditionally viewed by many as a less stressful and secure work environment offering high social standing and satisfying, autonomous work. However, this has changed over the past few decades and university teachers and employees are faced with a multitude of stressful issues. This study aimed to investigate the extent, sources and consequences of occupational stress among employees of the College of Health Sciences, Addis Ababa University. A quantitative, descriptive cross-sectional survey design was employed using the ASSET tool of occupational stress to which a six-items turnover intention tool was added. Both academic and non-academic (administrative and health professional) staff were enrolled. The study data were collected over a two-month period, from March 15, 2021– May 14, 2021. The explanatory power and predictive strengths of occupational stressors on the different outcome variables were examined using structural equation modeling (SEM) while differences among different demographic groups were assessed using independent samples t-test and oneway ANOVA. In comparison with the normative values of the ASSET tool, the participants of the current study showed higher levels of stress in terms of Work Relationship, Job Control, Resources and Communication, Pay and Benefits, and Job Dissatisfaction. On the other hand, lower levels of stress in terms of Work-Life Balance, Job Overload and Job Security were reported. Of the different categories of staff, academic staff were found to score the least in terms of the seven dimensions of job stressors except for Pay and Benefits. They also exhibited the lowest scores of Job Dissatisfaction and Turnover Intention. The SEM analysis showed that Work Relationship exerted the strongest effect on Job Dissatisfaction (β = .270, p < .001) followed by Resources and Communication (β = .210, p < .001). In turn, Job Dissatisfaction was found to exert the strongest effect on Turnover Intention (β = .279, p<.001). In terms of demographics, females reported significantly higher scores in terms of Turnover Intention than male employees. Employees with 1-5 years of work experience also exhibited significantly higher scores of Job Dissatisfaction, significantly lower scores of OC2E and EC2O compared to employees of longer work experience. Furthermore, employees with PhD and Specialty certificate showed the lowest scores of Job Dissatisfaction while those with Diploma and first degree reported the highest scores of Turnover Intention. Being high-risk groups, the administrative and health professional staff as well as newly recruited junior staff and those with lower qualifications should be targeted first if resources intended to tackle the impacts of work stress on individual employees and the organization are obtained. In addition, of the different dimensions of work stressors, attention should be focused on factors related to Work Relationship, Resources and Communication, and Pay and Benefits.